PARSIPPANY, N.J., March 01, 2017 (GLOBE NEWSWIRE) — Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported financial results for 2016 and its outlook for 2017.  The company is also announcing positive topline results for its Phase 4 study of EXPAREL® in total knee arthroplasty, or TKA. “We made important progress in 2016 […]